Vapiprost-impurities | Pharmaffiliates

Vapiprost

Vapiprost events and occlusive vascular disease. Phase III trials were underway in Japan for the treatment of deep vein thrombosis. Reference standards of Vapiprost API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Vapiprost - API Standards 
    [catalogue_number] => PA 22 58000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 477.63
    [form] => C30H39NO4
    [cas] => 85505-64-2
    [pslug] => 85505-64-2-vapiprost-api-pa2258000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 22 58000

Vapiprost - API Standards


  • Catalogue No.:PA 22 58000

  • CAS :

    85505-64-2

  • Molecular Formula : C30H39NO4

  • Molecular Weight : 477.63